Cargando…

The Endogenous Opioid System in Schizophrenia and Treatment Resistant Schizophrenia: Increased Plasma Endomorphin 2, and κ and μ Opioid Receptors Are Associated with Interleukin-6

Background: activation of the immune-inflammatory response system (IRS) and the compensatory immune-regulatory system (CIRS) plays a key role in schizophrenia (SCZ) and treatment resistant SCZ. There are only a few data on immune and endogenous opioid system (EOS) interactions in SCZ and treatment r...

Descripción completa

Detalles Bibliográficos
Autores principales: Moustafa, Shatha Rouf, Al-Rawi, Khalid F., Stoyanov, Drozdstoi, Al-Dujaili, Arafat Hussein, Supasitthumrong, Thitiporn, Al-Hakeim, Hussein Kadhem, Maes, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7554941/
https://www.ncbi.nlm.nih.gov/pubmed/32858974
http://dx.doi.org/10.3390/diagnostics10090633
_version_ 1783593891307454464
author Moustafa, Shatha Rouf
Al-Rawi, Khalid F.
Stoyanov, Drozdstoi
Al-Dujaili, Arafat Hussein
Supasitthumrong, Thitiporn
Al-Hakeim, Hussein Kadhem
Maes, Michael
author_facet Moustafa, Shatha Rouf
Al-Rawi, Khalid F.
Stoyanov, Drozdstoi
Al-Dujaili, Arafat Hussein
Supasitthumrong, Thitiporn
Al-Hakeim, Hussein Kadhem
Maes, Michael
author_sort Moustafa, Shatha Rouf
collection PubMed
description Background: activation of the immune-inflammatory response system (IRS) and the compensatory immune-regulatory system (CIRS) plays a key role in schizophrenia (SCZ) and treatment resistant SCZ. There are only a few data on immune and endogenous opioid system (EOS) interactions in SCZ and treatment resistant SCZ. Methods: we examined serum β-endorphin, endomorphin-2 (EM2), mu-opioid (MOR) and kappa-opioid (KOR) receptors, and interleukin (IL)-6 and IL-10 in 60 non responders to treatment (NRTT), 55 partial RTT (PRTT) and 43 normal controls. Results: serum EM2, KOR, MOR, IL-6 and IL-10 were significantly increased in SCZ as compared with controls. β-endorphin, EM2, MOR and IL-6 were significantly higher in NRTT than in PRTT. There were significant correlations between IL-6, on the one hand, and β-endorphin, EM2, KOR, and MOR, on the other, while IL-10 was significantly correlated with MOR only. A large part of the variance in negative symptoms, psychosis, hostility, excitation, mannerism, psychomotor retardation and formal thought disorders was explained by the combined effects of EM2 and MOR with or without IL-6 while increased KOR was significantly associated with all symptom dimensions. Increased MOR, KOR, EM2 and IL-6 were also associated with neurocognitive impairments including in episodic, semantic and working memory and executive functions. Conclusion: the EOS contributes to SCZ symptomatology, neurocognitive impairments and a non-response to treatment. In SCZ, EOS peptides/receptors may exert CIRS functions, whereas increased KOR levels may contribute to the pathophysiology of SCZ and EM2 and KOR to a non-response to treatment.
format Online
Article
Text
id pubmed-7554941
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-75549412020-10-14 The Endogenous Opioid System in Schizophrenia and Treatment Resistant Schizophrenia: Increased Plasma Endomorphin 2, and κ and μ Opioid Receptors Are Associated with Interleukin-6 Moustafa, Shatha Rouf Al-Rawi, Khalid F. Stoyanov, Drozdstoi Al-Dujaili, Arafat Hussein Supasitthumrong, Thitiporn Al-Hakeim, Hussein Kadhem Maes, Michael Diagnostics (Basel) Article Background: activation of the immune-inflammatory response system (IRS) and the compensatory immune-regulatory system (CIRS) plays a key role in schizophrenia (SCZ) and treatment resistant SCZ. There are only a few data on immune and endogenous opioid system (EOS) interactions in SCZ and treatment resistant SCZ. Methods: we examined serum β-endorphin, endomorphin-2 (EM2), mu-opioid (MOR) and kappa-opioid (KOR) receptors, and interleukin (IL)-6 and IL-10 in 60 non responders to treatment (NRTT), 55 partial RTT (PRTT) and 43 normal controls. Results: serum EM2, KOR, MOR, IL-6 and IL-10 were significantly increased in SCZ as compared with controls. β-endorphin, EM2, MOR and IL-6 were significantly higher in NRTT than in PRTT. There were significant correlations between IL-6, on the one hand, and β-endorphin, EM2, KOR, and MOR, on the other, while IL-10 was significantly correlated with MOR only. A large part of the variance in negative symptoms, psychosis, hostility, excitation, mannerism, psychomotor retardation and formal thought disorders was explained by the combined effects of EM2 and MOR with or without IL-6 while increased KOR was significantly associated with all symptom dimensions. Increased MOR, KOR, EM2 and IL-6 were also associated with neurocognitive impairments including in episodic, semantic and working memory and executive functions. Conclusion: the EOS contributes to SCZ symptomatology, neurocognitive impairments and a non-response to treatment. In SCZ, EOS peptides/receptors may exert CIRS functions, whereas increased KOR levels may contribute to the pathophysiology of SCZ and EM2 and KOR to a non-response to treatment. MDPI 2020-08-26 /pmc/articles/PMC7554941/ /pubmed/32858974 http://dx.doi.org/10.3390/diagnostics10090633 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Moustafa, Shatha Rouf
Al-Rawi, Khalid F.
Stoyanov, Drozdstoi
Al-Dujaili, Arafat Hussein
Supasitthumrong, Thitiporn
Al-Hakeim, Hussein Kadhem
Maes, Michael
The Endogenous Opioid System in Schizophrenia and Treatment Resistant Schizophrenia: Increased Plasma Endomorphin 2, and κ and μ Opioid Receptors Are Associated with Interleukin-6
title The Endogenous Opioid System in Schizophrenia and Treatment Resistant Schizophrenia: Increased Plasma Endomorphin 2, and κ and μ Opioid Receptors Are Associated with Interleukin-6
title_full The Endogenous Opioid System in Schizophrenia and Treatment Resistant Schizophrenia: Increased Plasma Endomorphin 2, and κ and μ Opioid Receptors Are Associated with Interleukin-6
title_fullStr The Endogenous Opioid System in Schizophrenia and Treatment Resistant Schizophrenia: Increased Plasma Endomorphin 2, and κ and μ Opioid Receptors Are Associated with Interleukin-6
title_full_unstemmed The Endogenous Opioid System in Schizophrenia and Treatment Resistant Schizophrenia: Increased Plasma Endomorphin 2, and κ and μ Opioid Receptors Are Associated with Interleukin-6
title_short The Endogenous Opioid System in Schizophrenia and Treatment Resistant Schizophrenia: Increased Plasma Endomorphin 2, and κ and μ Opioid Receptors Are Associated with Interleukin-6
title_sort endogenous opioid system in schizophrenia and treatment resistant schizophrenia: increased plasma endomorphin 2, and κ and μ opioid receptors are associated with interleukin-6
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7554941/
https://www.ncbi.nlm.nih.gov/pubmed/32858974
http://dx.doi.org/10.3390/diagnostics10090633
work_keys_str_mv AT moustafashatharouf theendogenousopioidsysteminschizophreniaandtreatmentresistantschizophreniaincreasedplasmaendomorphin2andkandmopioidreceptorsareassociatedwithinterleukin6
AT alrawikhalidf theendogenousopioidsysteminschizophreniaandtreatmentresistantschizophreniaincreasedplasmaendomorphin2andkandmopioidreceptorsareassociatedwithinterleukin6
AT stoyanovdrozdstoi theendogenousopioidsysteminschizophreniaandtreatmentresistantschizophreniaincreasedplasmaendomorphin2andkandmopioidreceptorsareassociatedwithinterleukin6
AT aldujailiarafathussein theendogenousopioidsysteminschizophreniaandtreatmentresistantschizophreniaincreasedplasmaendomorphin2andkandmopioidreceptorsareassociatedwithinterleukin6
AT supasitthumrongthitiporn theendogenousopioidsysteminschizophreniaandtreatmentresistantschizophreniaincreasedplasmaendomorphin2andkandmopioidreceptorsareassociatedwithinterleukin6
AT alhakeimhusseinkadhem theendogenousopioidsysteminschizophreniaandtreatmentresistantschizophreniaincreasedplasmaendomorphin2andkandmopioidreceptorsareassociatedwithinterleukin6
AT maesmichael theendogenousopioidsysteminschizophreniaandtreatmentresistantschizophreniaincreasedplasmaendomorphin2andkandmopioidreceptorsareassociatedwithinterleukin6
AT moustafashatharouf endogenousopioidsysteminschizophreniaandtreatmentresistantschizophreniaincreasedplasmaendomorphin2andkandmopioidreceptorsareassociatedwithinterleukin6
AT alrawikhalidf endogenousopioidsysteminschizophreniaandtreatmentresistantschizophreniaincreasedplasmaendomorphin2andkandmopioidreceptorsareassociatedwithinterleukin6
AT stoyanovdrozdstoi endogenousopioidsysteminschizophreniaandtreatmentresistantschizophreniaincreasedplasmaendomorphin2andkandmopioidreceptorsareassociatedwithinterleukin6
AT aldujailiarafathussein endogenousopioidsysteminschizophreniaandtreatmentresistantschizophreniaincreasedplasmaendomorphin2andkandmopioidreceptorsareassociatedwithinterleukin6
AT supasitthumrongthitiporn endogenousopioidsysteminschizophreniaandtreatmentresistantschizophreniaincreasedplasmaendomorphin2andkandmopioidreceptorsareassociatedwithinterleukin6
AT alhakeimhusseinkadhem endogenousopioidsysteminschizophreniaandtreatmentresistantschizophreniaincreasedplasmaendomorphin2andkandmopioidreceptorsareassociatedwithinterleukin6
AT maesmichael endogenousopioidsysteminschizophreniaandtreatmentresistantschizophreniaincreasedplasmaendomorphin2andkandmopioidreceptorsareassociatedwithinterleukin6